Vijayaraghavan Maya, Freitas Daniel, Bangsberg David R, Miaskowski Christine, Kushel Margot B
Moores UCSD Cancer Center, University of California, San Diego, 3855 Health Sciences Drive, San Diego, CA 92093, USA.
University of California, San Francisco, 521 Parnassus Avenue, San Francisco, CA 94117, USA.
Drug Alcohol Depend. 2014 Oct 1;143:263-7. doi: 10.1016/j.drugalcdep.2014.06.044. Epub 2014 Jul 27.
Non-opioid psychotherapeutic medications significantly increase the risk of opioid overdose-related deaths. We prospectively followed HIV-infected indigent adults sampled from the community to examine rates of and factors associated with non-medical use of benzodiazepines, muscle relaxants, and prescription stimulants.
We interviewed participants quarterly for 2 years about alcohol and illicit substance use; depression; use of prescribed opioid analgesics, benzodiazepines and muscle relaxants; opioid analgesic misuse; and non-medical use (i.e., use without a prescription) of benzodiazepines, muscle relaxants, and prescription stimulants. Using mixed-effects multivariate logistic regression, we determined factors associated with non-medical use of benzodiazepines, muscle relaxants, and prescription stimulants.
Among the 296 participants at enrollment, 52.0% reported taking opioid analgesics that had been prescribed, 17.9% took benzodiazepines that had been prescribed, and 8.1% took muscle relaxants that had been prescribed. Over the 2-year study interval, 53.4% reported prescription opioid misuse, 25.3% reported non-medical use of benzodiazepines, 11.5% reported non-medical use of muscle relaxants, and 6.1% reported non-medical use of prescription stimulants. In multivariable analysis, opioid analgesic misuse in the past 90 days was associated with non-medical use of benzodiazepines, muscle relaxants, and prescription stimulants during the same time interval. Illicit substance use and depression were not associated with non-medical use of these medications.
Prescription opioid analgesic misuse is associated with non-medical use of other psychotherapeutic medications. Health care providers should monitor for non-medical use of a broad array of psychoactive medications among high-risk populations to minimize harm.
非阿片类精神治疗药物显著增加了与阿片类药物过量相关死亡的风险。我们对从社区抽取的感染艾滋病毒的贫困成年人进行了前瞻性随访,以研究苯二氮䓬类药物、肌肉松弛剂和处方兴奋剂的非医疗使用发生率及相关因素。
我们在两年时间里每季度对参与者进行一次访谈,内容包括酒精和非法药物使用情况、抑郁状况、处方阿片类镇痛药、苯二氮䓬类药物和肌肉松弛剂的使用情况、阿片类镇痛药滥用情况,以及苯二氮䓬类药物、肌肉松弛剂和处方兴奋剂的非医疗使用情况(即无处方使用)。我们使用混合效应多变量逻辑回归分析来确定与苯二氮䓬类药物、肌肉松弛剂和处方兴奋剂非医疗使用相关的因素。
在入组的296名参与者中,52.0%报告服用过处方阿片类镇痛药,17.9%服用过处方苯二氮䓬类药物,8.1%服用过处方肌肉松弛剂。在为期两年的研究期间,53.4%报告有处方阿片类药物滥用情况,25.3%报告有苯二氮䓬类药物非医疗使用情况,11.5%报告有肌肉松弛剂非医疗使用情况,6.1%报告有处方兴奋剂非医疗使用情况。在多变量分析中,过去90天内的阿片类镇痛药滥用与同一时间段内苯二氮䓬类药物、肌肉松弛剂和处方兴奋剂的非医疗使用相关。非法药物使用和抑郁与这些药物的非医疗使用无关。
处方阿片类镇痛药滥用与其他精神治疗药物的非医疗使用相关。医疗保健提供者应监测高危人群中多种精神活性药物的非医疗使用情况,以尽量减少危害。